Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Exel Industries SA
PAR:EXE

Watchlist Manager
Exel Industries SA Logo
Exel Industries SA
PAR:EXE
Watchlist
Price: 39.8 EUR -0.5% Market Closed
Market Cap: €270.2m
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Assets
+
3Y
-6%
5Y
+10%
10Y
+31%
Liabilities
+
3Y
-21%
5Y
-11%
10Y
+3%
Equity
+
3Y
+11%
5Y
+36%
10Y
+67%

Balance Sheet Decomposition
Exel Industries SA

Balance Sheet
Exel Industries SA

Rotate your device to view
Balance Sheet
Currency: EUR
Aug-2002 Aug-2003 Aug-2004 Aug-2005 Aug-2006 Aug-2007 Aug-2008 Aug-2009 Aug-2010 Aug-2011 Aug-2012 Aug-2013 Aug-2014 Aug-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022 Sep-2023 Sep-2024 Sep-2025
Assets
Cash & Cash Equivalents
21
39
48
44
46
55
46
60
50
45
55
105
112
80
100
104
79
89
99
83
66
65
50
42
Cash
0
0
0
0
11
0
15
38
45
28
31
72
96
71
100
104
79
89
99
83
66
65
50
42
Cash Equivalents
21
39
48
44
34
55
30
22
5
17
24
33
16
9
0
0
0
0
0
0
0
0
0
0
Total Receivables
77
66
71
68
67
81
113
79
80
90
113
152
164
147
132
159
150
144
174
174
212
207
201
191
Accounts Receivables
67
60
63
61
62
71
107
70
74
80
103
136
151
135
119
134
134
120
150
158
181
186
182
166
Other Receivables
10
6
8
7
5
11
6
9
6
11
10
15
13
12
13
25
16
24
24
16
32
21
19
24
Inventory
45
48
48
51
52
61
113
95
86
118
144
177
200
199
211
189
232
228
220
247
304
299
296
271
Other Current Assets
0
1
1
0
3
0
4
3
4
4
7
7
7
8
9
9
4
5
5
6
9
10
8
10
Total Current Assets
143
153
168
162
166
197
276
237
220
257
318
440
482
434
452
460
466
466
498
510
591
580
555
513
PP&E Net
29
30
28
27
27
28
54
54
66
69
71
84
120
121
137
139
142
137
146
147
175
179
201
203
PP&E Gross
29
30
28
27
27
28
54
54
66
69
71
84
120
121
137
139
142
137
146
0
175
179
201
203
Accumulated Depreciation
38
41
44
47
50
52
103
108
115
123
132
205
226
239
248
256
266
253
259
0
329
332
346
350
Intangible Assets
2
1
1
2
1
1
1
1
1
1
1
2
2
2
13
14
14
13
31
32
28
24
20
15
Goodwill
15
14
13
10
11
11
26
26
26
25
25
60
56
58
66
64
64
65
63
64
71
72
72
71
Note Receivable
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
0
2
0
0
1
0
3
3
3
3
3
3
3
3
4
5
5
5
5
6
7
7
8
8
Other Long-Term Assets
1
2
0
0
4
4
6
7
9
9
11
15
21
24
25
20
18
25
21
23
21
27
31
30
Other Assets
15
14
13
10
11
11
26
26
26
25
25
60
56
58
66
64
64
65
63
64
71
72
72
71
Total Assets
190
N/A
201
+6%
209
+4%
201
-4%
210
+5%
241
+15%
364
+51%
327
-10%
324
-1%
364
+12%
429
+18%
604
+41%
684
+13%
643
-6%
697
+9%
702
+1%
709
+1%
711
+0%
765
+8%
781
+2%
893
+14%
889
0%
887
0%
840
-5%
Liabilities
Accounts Payable
36
33
34
32
31
42
58
27
32
45
54
65
69
62
57
70
62
49
59
70
71
80
60
64
Accrued Liabilities
21
26
21
26
0
0
30
32
27
29
36
43
43
26
29
33
33
31
33
42
41
51
49
47
Short-Term Debt
0
0
0
8
8
5
23
27
22
39
31
28
75
38
47
33
46
41
54
0
0
0
0
0
Current Portion of Long-Term Debt
20
15
23
3
2
1
2
20
10
4
16
40
59
39
45
49
50
53
79
82
129
103
103
77
Other Current Liabilities
5
6
11
7
32
41
19
13
14
21
49
39
46
54
47
45
39
70
92
116
108
101
104
91
Total Current Liabilities
82
80
88
75
73
89
131
119
105
139
185
216
292
219
226
229
230
243
318
311
349
334
317
279
Long-Term Debt
8
14
7
5
3
2
58
26
14
14
4
97
74
78
111
83
68
57
54
43
97
80
75
63
Deferred Income Tax
0
0
0
0
0
0
1
1
1
1
2
10
11
15
8
6
3
5
6
9
9
7
9
9
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
Other Liabilities
15
18
16
15
12
10
17
19
26
23
26
51
57
52
54
48
44
47
46
28
18
24
22
22
Total Liabilities
106
N/A
111
+5%
112
+0%
96
-15%
88
-8%
102
+16%
207
+103%
164
-21%
145
-12%
177
+22%
217
+22%
375
+73%
434
+16%
363
-16%
398
+10%
367
-8%
346
-6%
352
+2%
423
+20%
391
-7%
474
+21%
446
-6%
424
-5%
374
-12%
Equity
Common Stock
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
17
Retained Earnings
65
71
78
86
106
122
141
146
159
167
189
210
232
259
280
320
348
341
329
374
401
428
450
459
Additional Paid In Capital
3
3
3
3
0
0
0
0
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
Treasury Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Equity
0
0
0
0
0
0
0
0
1
1
4
0
1
0
0
3
5
2
7
3
0
5
6
12
Total Equity
85
N/A
90
+6%
98
+8%
105
+8%
123
+16%
139
+13%
158
+14%
163
+3%
179
+10%
187
+4%
212
+14%
229
+8%
251
+9%
279
+11%
299
+7%
336
+12%
363
+8%
359
-1%
342
-5%
390
+14%
420
+8%
443
+6%
463
+5%
466
+1%
Total Liabilities & Equity
190
N/A
201
+6%
209
+4%
201
-4%
210
+5%
241
+15%
364
+51%
327
-10%
324
-1%
364
+12%
429
+18%
604
+41%
684
+13%
643
-6%
697
+9%
702
+1%
709
+1%
711
+0%
765
+8%
781
+2%
893
+14%
889
0%
887
0%
840
-5%
Shares Outstanding
Common Shares Outstanding
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7
7

See Also

Summary
EXE intrinsic value, competitors valuation, and company profile.
DCF Valuation
EXE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EXE stock valuation using valuation multiples.
Wall Street Estimates
EXE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EXE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.